Caplight Directory>Companies>Veana Therapeutics-preview>Veana-therapeutics


Veana Therapeutics

Veana Therapeutics

Private
Portland, OregonHealthcare & Life Scienceshttps://www.veana-therapeutics.com/

Last Round

Seed

Jun 19, 2024

Total Funding Raised

$942,000

Momentum Score

25 /100

Company Overview

Veana Therapeutics is a clinical-stage biotechnology company that develops oral mitochondrial inhibitors intended for treating various cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

oral immunotherapyVIMO-001immuno-oncologysolid tumorsα-TEAoral cancer drugcancer pillimmunotherapy platformcancer stem cellsclinical-stage biotechpro-drugdrug licensingSmall Business Innovation ResearchSBIR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Veana Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Veana Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedJun 19, 2024
GrantAug 1, 2021
SeedMay 29, 2018
View all Funding Rounds

Veana Therapeutics Investors

Notable investors and investment history

InvestorRounds
NIH RADxGrant
CANCER FUNDSeed
View all Investors

Veana Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Veana Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Veana Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersPortland, Oregon
Employee Range2
Year Founded2012
Last FundingJun 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.